Answers are grounded in this paper and cite their sources.
Although previous articles have suggested that interferon beta may increase relapses in NMO, this is the first to illustrate an increase in AQP4 antibodies associated with such treatment.
No takes yet. Share an insight, caveat, or question.
Palace et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: